SSY Group (HKSE:02005) Capital Expenditure : HK$-540.43 Mil (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is SSY Group Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

SSY Group's cash flow for capital expenditures for the six months ended in Dec. 2024 was HK$-250 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-540.43 Mil.

SSY Group Capital Expenditure Historical Data

The historical data trend for SSY Group's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Capital Expenditure Chart

SSY Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Capital Expenditure

Get a 7-Day Free Trial

-321.52

-388.32

-418.12

-703.87

-540.43

SSY Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial															-181.83	-323.10	-380.77	-290.90	-249.52

SSY Group Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-540.43 Mil.

SSY Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Capital Expenditure

Traded in Other Exchanges

N/A

Address

Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG

Website

http://www.ssygroup.com.hk

SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

Executives

China Pharmaceutical Company Limited	2101 Beneficial owner
Qu Jiguang	2201 Interest of corporation controlled by you
Ubs Group Ag	2201 Interest of corporation controlled by you
Si Chuan Ke Lun Yao Ye Gu Fen You Xian Gong Si	2101 Beneficial owner

SSY Group Headlines

No Headlines